Rakuten Aspyrian changes name to Rakuten Medical

World |  News | 0 Comment | 01 Mar, 2019

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, announced that it has changed its name to Raku...Read more

Agilent announces new Library Prep System for NGS

World |  News | 0 Comment | 01 Mar, 2019

Agilent Technologies, Inc. recently announced a new next-generation sequencing (NGS) library preparation system designed to easily run complex DNA sequencing assays with the press of a butt...Read more

MTS to help medical device companies for 3D-Printed Spinal Implants

World |  News | 0 Comment | 28 Feb, 2019

MTS Systems Corporation, a leading global supplier of high-performance test systems, motion simulators and sensors, announced the use of MTS material test systems to develop 3D-printed, por...Read more

Amicus begins global research and gene therapy centre of excellence

World |  News | 0 Comment | 28 Feb, 2019

Amicus Therapeutics is establishing a new Global Research and Gene Therapy centre of Excellence in uCity Square in Philadelphia, PA, to advance its commit...Read more

Axial Biotherapeutics raises $25M in series b financing

World |  News | 0 Comment | 28 Feb, 2019

Axial Biotherapeutics, a biotechnology company building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases has announced the completion of a $25 mil...Read more

The CoWrks Foundry partners with Yale University

World |  News | 0 Comment | 28 Feb, 2019

To address growing health and social disparities in India and around the globe, The CoWrks Foundry has partnered with Yale University with support from the RMZ Foundation, to launch the Sus...Read more

Bausch Health to acquire assets of Synergy Pharma

World |  News | 0 Comment | 27 Feb, 2019

Bausch Health Companies Inc. has announced that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of appr...Read more

Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

World |  News | 0 Comment | 26 Feb, 2019

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in CNS diseases has annou...Read more

HOOKIPA Pharma raises $37.4M in Series D Financing

World |  News | 0 Comment | 26 Feb, 2019

HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platfor...Read more

Marinomed receives EUR 15M EIB financing

World |  News | 0 Comment | 26 Feb, 2019

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutical Company developing innovative therapies for allergy, respiratory an...Read more

FDA & Flatiron Health expand Data Cancer Research collaboration

World |  News | 0 Comment | 27 Feb, 2019

Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Administration (FDA) announced a two-year renewal and expansion of their re...Read more

Novartis to license Akcea-Ionis cardiac disease drug

World |  News | 0 Comment | 26 Feb, 2019

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to license AKCEA-APO(a)-LRx, a drug to treat patients with elevated levels of...Read more

Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

World |  News | 0 Comment | 25 Feb, 2019

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more

GE to sell Biopharma business for $21.4B to Danaher

World |  News | 0 Comment | 26 Feb, 2019

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration of $21.4 billion, including $21 billion in cash as well as Danaher&rs...Read more

Sysmex Inostics’ OncoBEAM shows superior performance in mutation detection for HCC

World |  News | 0 Comment | 25 Feb, 2019

Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic eff...Read more

EC approves Pfizer's ZIRABEV, a biosimilar to Avastin

World |  News | 0 Comment | 25 Feb, 2019

Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectabl...Read more

Roche to acquire Spark Therapeutics for $ 4.3B

World |  News | 0 Comment | 25 Feb, 2019

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction. Thi...Read more

AbbVie and Voyager Therapeutics announce collaboration

World |  News | 0 Comment | 25 Feb, 2019

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases has announc...Read more